FDA Inspection 1115086 — Zhejiang Dayang Biotech Group Co. Ltd.
The FDA completed an inspection of Zhejiang Dayang Biotech Group Co. Ltd. on December 19, 2019 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 19, 2019
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hangzhou (China)